Anaemia and transfusion triggers in critically ill patients – What we have learnt thus far
نویسندگان
چکیده
منابع مشابه
Proteomics in aortic aneurysm--what have we learnt so far?
Aortic aneurysm is a deceptively indolent disease that can cause severe complications such as aortic rupture and dissection. In the normal aorta, vascular smooth muscle cells within the medial layer produce and sustain the extracellular matrix (ECM) that provides structural support but also retains soluble growth factors and regulates their distribution. Although the ECM is an obvious target to...
متن کاملWhat have we learnt
Author: Katie Schenk (independent consultant for JLICA) 2122 Massachusetts Avenue NW, Apt 614 Washington DC, 20008 USA Tel: +1 202 468 5537 Email: [email protected] Executive Summary: What have we learnt from evaluations of community OVC programmes? • Approaching twenty years after the first studies drew attention to the issues faced by children affected by HIV, evaluation data from OVC p...
متن کاملAntimalarial metabolization: what have we learnt so far?
Considering malaria is a highly devastating disease of mankind, total eradication of malaria seems to be an uphill task, the only relief from this disease is achieved by usage of antimalarial drugs. Since malaria is associated with humans from time immemorial, usage of traditional substances to most presently effective antimalarial have been recorded to cure this disease. With the advent of mod...
متن کاملCOPD in farmers: what have we learnt?
Farming is a complex occupation, comprising a spectrum of activities that range from small-scale hobby farms to large-scale corporate farms. The activities, and thus the occupational exposures, on a farm are dictated by the type and size of the farm, as well as cultivation practices [1]. The farmers themselves are also diverse, living and working on farms alone or with family members or employe...
متن کاملIn vitro interaction of colloidal nanoparticles with mammalian cells: What have we learned thus far?
The interfacing of colloidal nanoparticles with mammalian cells is now well into its second decade. In this review our goal is to highlight the more generally accepted concepts that we have gleaned from nearly twenty years of research. While details of these complex interactions strongly depend, amongst others, upon the specific properties of the nanoparticles used, the cell type, and their env...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Intensive Care Society
سال: 2018
ISSN: 1751-1437
DOI: 10.1177/1751143718783615